Rationale and design of the third Vasodilator-Heart Failure Trial (V-HeFT III): Felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure
- 15 May 1996
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 77 (12) , 1078-1082
- https://doi.org/10.1016/s0002-9149(96)00136-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trialJournal of the American College of Cardiology, 1993
- Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme InhibitorsNew England Journal of Medicine, 1993
- Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dogJournal of the American College of Cardiology, 1993
- Adrenergic effects on the biology of the adult mammalian cardiocyte.Circulation, 1992
- Cardiac myocyte necrosis induced by angiotensin II.Circulation Research, 1991
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Nebivolol Increases Survival in Cardiomyopathic Hamsters with Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1991
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985
- Calcium channel blockers in congestive heart failure: Theoretic considerations and clinical experienceThe American Journal of Medicine, 1985